Market Cap ₹62 Cr.
Stock P/E 64.4
P/B 0.6
Current Price ₹4.1
Book Value ₹ 7.2
Face Value 2
52W High ₹6.8
Dividend Yield 0%
52W Low ₹ 2
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 10 | 10 | 5 | 5 | 4 | 10 | 3 | 3 | 3 | 3 |
Other Income | 0 | 1 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 1 |
Total Income | 10 | 10 | 5 | 5 | 4 | 15 | 3 | 4 | 3 | 4 |
Total Expenditure | 9 | 11 | 4 | 4 | 3 | 16 | 3 | 3 | 3 | 4 |
Operating Profit | 0 | -1 | 1 | 1 | 2 | -2 | 0 | 1 | 0 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | -1 | 1 | 0 | 1 | -2 | 0 | 0 | 0 | 0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 |
Profit After Tax | 0 | -1 | 1 | 0 | 1 | -2 | 0 | 0 | 0 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | -1 | 1 | 0 | 1 | -2 | 0 | 0 | 0 | 0 |
Adjusted Earnings Per Share | 0 | -0.1 | 0.1 | 0 | 0.1 | -0.1 | 0 | 0 | 0 | 0 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 10 | 12 | 13 | 53 | 105 | 60 | 83 | 8 | 37 | 23 | 12 |
Other Income | 0 | 0 | 1 | 0 | 0 | 4 | 0 | 1 | 1 | 5 | 1 |
Total Income | 10 | 12 | 14 | 53 | 105 | 64 | 83 | 9 | 38 | 28 | 14 |
Total Expenditure | 8 | 24 | 18 | 49 | 101 | 55 | 80 | 8 | 37 | 27 | 13 |
Operating Profit | 2 | -13 | -4 | 4 | 4 | 9 | 3 | 1 | 1 | 1 | 1 |
Interest | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Depreciation | 1 | 1 | 4 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | -14 | -60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | -29 | -67 | 2 | 3 | 7 | 2 | 0 | 0 | 0 | 0 |
Provision for Tax | 0 | 0 | -0 | 0 | -1 | 1 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 0 | -29 | -67 | 2 | 4 | 6 | 2 | 0 | 0 | 0 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | -29 | -67 | 2 | 4 | 6 | 2 | 0 | 0 | 0 | 0 |
Adjusted Earnings Per Share | 0 | -4 | -9.3 | 0.3 | 0.5 | 0.6 | 0.2 | 0 | 0 | 0 | 0 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -38% | -35% | -26% | 0% |
Operating Profit CAGR | 0% | -31% | -24% | 0% |
PAT CAGR | 0% | -100% | -100% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 68% | 29% | 21% | 24% |
ROE Average | 0% | 0% | 3% | -23% |
ROCE Average | 1% | 1% | 4% | -21% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 113 | 81 | 14 | 16 | 24 | 96 | 98 | 101 | 101 | 101 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 1 | 1 | 1 | -0 | 3 | 3 | 0 | -0 | -0 |
Total Current Liabilities | 9 | 13 | 15 | 29 | 15 | 16 | 22 | 29 | 45 | 74 |
Total Liabilities | 125 | 96 | 29 | 45 | 38 | 116 | 124 | 130 | 145 | 175 |
Fixed Assets | 7 | 30 | 5 | 3 | 2 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 36 | 0 | 0 | 0 | 0 | 68 | 68 | 68 | 68 | 68 |
Total Current Assets | 78 | 26 | 25 | 43 | 37 | 47 | 55 | 61 | 77 | 107 |
Total Assets | 125 | 96 | 29 | 45 | 38 | 116 | 124 | 130 | 145 | 175 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
Cash Flow from Operating Activities | 2 | 28 | 2 | -2 | -2 | -2 | 2 | -4 | -12 | 0 |
Cash Flow from Investing Activities | -1 | -27 | -0 | -0 | -0 | -63 | 0 | -3 | -0 | 0 |
Cash Flow from Financing Activities | -0 | -1 | -1 | 2 | 4 | 65 | -3 | 7 | 12 | -0 |
Net Cash Inflow / Outflow | -0 | 0 | 0 | -0 | 1 | -1 | -1 | 0 | -0 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0 | -4 | -9.28 | 0.32 | 0.47 | 0.63 | 0.17 | 0.02 | 0.01 | 0.03 |
CEPS(Rs) | 0.2 | -3.87 | -8.78 | 0.61 | 0.57 | 0.64 | 0.18 | 0.03 | 0.01 | 0.04 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 15.01 | 5.76 | 1.91 | 2.23 | 2.93 | 9.74 | 9.91 | 10.17 | 10.17 | 8.94 |
Core EBITDA Margin(%) | 19.61 | -108.58 | -33.32 | 8.4 | 3.7 | 8.47 | 3.05 | -0.49 | 0.25 | -15.34 |
EBIT Margin(%) | 6.85 | -235.06 | -498.49 | 4.47 | 2.97 | 14.33 | 3.12 | 12.16 | 2.17 | 5.38 |
Pre Tax Margin(%) | 0.37 | -246.42 | -498.5 | 4.47 | 2.97 | 12.25 | 2.33 | 4.21 | 0.4 | 2.03 |
PAT Margin (%) | 0.26 | -247.13 | -498 | 4.34 | 3.64 | 10.27 | 2.04 | 2.58 | 0.15 | 1.49 |
Cash Profit Margin (%) | 14.21 | -239.06 | -471.48 | 8.27 | 4.38 | 10.52 | 2.2 | 3.86 | 0.31 | 1.75 |
ROA(%) | 0.02 | -26.26 | -107.6 | 6.22 | 9.09 | 8.05 | 1.4 | 0.17 | 0.04 | 0.22 |
ROE(%) | 0.02 | -38.51 | -242.11 | 15.52 | 19.19 | 10.35 | 1.73 | 0.21 | 0.06 | 0.35 |
ROCE(%) | 0.61 | -35.08 | -216.24 | 12.3 | 12.14 | 13.28 | 2.56 | 0.95 | 0.7 | 1.04 |
Receivable days | 1771.81 | 1132.8 | 638.62 | 215.36 | 124.4 | 225.79 | 211.11 | 2462.83 | 646.75 | 1381.24 |
Inventory Days | 955.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payable days | 1608.2 | 0 | 0 | 0 | 0 | 0 | 68.38 | 0 | 0 | 0 |
PER(x) | 150 | 0 | 0 | 11.51 | 5.52 | 2.92 | 4.88 | 72.43 | 1266.07 | 88.06 |
Price/Book(x) | 0.04 | 0.16 | 0.39 | 1.66 | 0.89 | 0.19 | 0.08 | 0.15 | 0.7 | 0.31 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.71 | 0.86 | 0.64 | 0.6 | 0.24 | 0.36 | 0.13 | 2.79 | 2.43 | 2.2 |
EV/Core EBITDA(x) | 3.44 | -0.79 | -2.16 | 7.17 | 6.47 | 2.48 | 3.91 | 20.73 | 104.6 | 39.01 |
Net Sales Growth(%) | 0 | 16.71 | 15.14 | 296.33 | 95.7 | -42.25 | 36.64 | -90.09 | 355.74 | -37.11 |
EBIT Growth(%) | 0 | -4105.55 | -144.18 | 103.56 | 30.12 | 178.12 | -70.24 | -61.38 | -18.81 | 56.31 |
PAT Growth(%) | 0 | 0 | -132.02 | 103.46 | 64.06 | 62.92 | -72.9 | -87.44 | -73.54 | 527.01 |
EPS Growth(%) | 0 | 0 | -132.02 | 103.46 | 47.56 | 32.6 | -72.9 | -87.41 | -73.83 | 453.57 |
Debt/Equity(x) | 0.03 | 0.08 | 0.24 | 0.35 | 0.24 | 0.05 | 0.03 | 0.08 | 0.2 | 0.21 |
Current Ratio(x) | 8.98 | 1.97 | 1.7 | 1.49 | 2.48 | 2.89 | 2.47 | 2.14 | 1.72 | 1.44 |
Quick Ratio(x) | 5.95 | 1.97 | 1.7 | 1.49 | 2.48 | 2.89 | 2.47 | 2.14 | 1.72 | 1.44 |
Interest Cover(x) | 1.06 | -20.68 | 0 | 748.25 | 555.79 | 6.9 | 3.93 | 1.53 | 1.22 | 1.61 |
Total Debt/Mcap(x) | 0.84 | 0.5 | 0.62 | 0.21 | 0.27 | 0.25 | 0.3 | 0.49 | 0.29 | 0.68 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 19.06 | 19.06 | 18.44 | 17.71 | 16.58 | 15.31 | 13.32 | 13.32 | 24.89 | 24.89 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 80.94 | 80.94 | 81.56 | 82.29 | 83.42 | 84.69 | 86.68 | 86.68 | 75.11 | 75.11 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 1.89 | 1.89 | 1.82 | 1.75 | 1.75 | 1.73 | 1.73 | 1.73 | 3.73 | 3.73 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 8.01 | 8.01 | 8.07 | 8.14 | 8.8 | 9.57 | 11.26 | 11.26 | 11.26 | 11.26 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9.9 | 9.9 | 9.9 | 9.9 | 10.55 | 11.3 | 12.98 | 12.98 | 14.98 | 14.98 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About